These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36594785)

  • 21. Preparation of Biodegradable Polymeric Nanocapsules for Treatment of Malignant Tumor Using Coaxial Capillary Microfluidic Device.
    Xu Y; Hu B; Xu J; Wu J; Ye B
    Cancer Biother Radiopharm; 2020 Oct; 35(8):570-580. PubMed ID: 32196366
    [No Abstract]   [Full Text] [Related]  

  • 22. Characterization of nanoparticles for therapeutics.
    Hall JB; Dobrovolskaia MA; Patri AK; McNeil SE
    Nanomedicine (Lond); 2007 Dec; 2(6):789-803. PubMed ID: 18095846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mulberry-like dual-drug complicated nanocarriers assembled with apogossypolone amphiphilic starch micelles and doxorubicin hyaluronic acid nanoparticles for tumor combination and targeted therapy.
    Li K; Liu H; Gao W; Chen M; Zeng Y; Liu J; Xu L; Wu D
    Biomaterials; 2015 Jan; 39():131-44. PubMed ID: 25477180
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nanoparticles in targeted cancer therapy: mesoporous silica nanoparticles entering preclinical development stage.
    Rosenholm JM; Mamaeva V; Sahlgren C; Lindén M
    Nanomedicine (Lond); 2012 Jan; 7(1):111-20. PubMed ID: 22191780
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protein corona change the drug release profile of nanocarriers: the "overlooked" factor at the nanobio interface.
    Behzadi S; Serpooshan V; Sakhtianchi R; Müller B; Landfester K; Crespy D; Mahmoudi M
    Colloids Surf B Biointerfaces; 2014 Nov; 123():143-9. PubMed ID: 25262409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nanotechnology in therapeutics: a focus on nanoparticles as a drug delivery system.
    Bamrungsap S; Zhao Z; Chen T; Wang L; Li C; Fu T; Tan W
    Nanomedicine (Lond); 2012 Aug; 7(8):1253-71. PubMed ID: 22931450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stimuli-responsive and biomimetic delivery systems for sepsis and related complications.
    Ismail EA; Devnarain N; Govender T; Omolo CA
    J Control Release; 2022 Dec; 352():1048-1070. PubMed ID: 36372385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of the surface modification, size, and shape on cellular uptake of nanoparticles.
    Salatin S; Maleki Dizaj S; Yari Khosroushahi A
    Cell Biol Int; 2015 Aug; 39(8):881-90. PubMed ID: 25790433
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipid based nanocarriers: a translational perspective.
    Mishra DK; Shandilya R; Mishra PK
    Nanomedicine; 2018 Oct; 14(7):2023-2050. PubMed ID: 29944981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Reactive oxygen species stimuli-responsive nanocarriers].
    Zhou W; Yang K; Zhao B; Zhang L; Zhang Y
    Se Pu; 2021 Feb; 39(2):118-124. PubMed ID: 34227343
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Green Synthesized Montmorillonite/Carrageenan/Fe
    Yew YP; Shameli K; Mohamad SE; Lee KX; Teow SY
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32659939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Superiority of TPGS-loaded micelles in the brain delivery of vinpocetine via administration of thermosensitive intranasal gel.
    Ahmed TA; El-Say KM; Ahmed OA; Aljaeid BM
    Int J Nanomedicine; 2019; 14():5555-5567. PubMed ID: 31413562
    [No Abstract]   [Full Text] [Related]  

  • 33. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile.
    Rafiei P; Haddadi A
    Int J Nanomedicine; 2017; 12():935-947. PubMed ID: 28184163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Core-shell structured gel-nanocarriers for sustained drug release and enhanced antitumor effect.
    He W; Lv Y; Zhao Y; Xu C; Jin Z; Qin C; Yin L
    Int J Pharm; 2015 Apr; 484(1-2):163-71. PubMed ID: 25724136
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amphiphilic Y shaped miktoarm star copolymer for anticancer hydrophobic and hydrophilic drugs codelivery: Synthesis, characterization, in vitro, and in vivo biocompatibility study.
    Aghajanzadeh M; Zamani M; Rashidzadeh H; Rostamizadeh K; Sharafi A; Danafar H
    J Biomed Mater Res A; 2018 Nov; 106(11):2817-2826. PubMed ID: 29908009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipid nanocarriers: influence of lipids on product development and pharmacokinetics.
    Pathak K; Keshri L; Shah M
    Crit Rev Ther Drug Carrier Syst; 2011; 28(4):357-93. PubMed ID: 21967401
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mesoporous silica nanoparticles with organo-bridged silsesquioxane framework as innovative platforms for bioimaging and therapeutic agent delivery.
    Du X; Li X; Xiong L; Zhang X; Kleitz F; Qiao SZ
    Biomaterials; 2016 Jun; 91():90-127. PubMed ID: 27017579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nanomachines and Other Caps on Mesoporous Silica Nanoparticles for Drug Delivery.
    Chen W; Glackin CA; Horwitz MA; Zink JI
    Acc Chem Res; 2019 Jun; 52(6):1531-1542. PubMed ID: 31082188
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fabrication of Niclosamide loaded solid lipid nanoparticles: in vitro characterization and comparative in vivo evaluation.
    Rehman MU; Khan MA; Khan WS; Shafique M; Khan M
    Artif Cells Nanomed Biotechnol; 2018 Dec; 46(8):1926-1934. PubMed ID: 29113501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Are existing standard methods suitable for the evaluation of nanomedicines: some case studies.
    Gioria S; Caputo F; Urbán P; Maguire CM; Bremer-Hoffmann S; Prina-Mello A; Calzolai L; Mehn D
    Nanomedicine (Lond); 2018 Mar; 13(5):539-554. PubMed ID: 29381129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.